Clinical efficacy and safety of mirabegron and imidafenacin in women with overactive bladder: A randomized crossover study (the MICRO study).

about

Clinical efficacy and safety of mirabegron and imidafenacin in women with overactive bladder: A randomized crossover study (the MICRO study).

Item

http://www.wikidata.org/entity/Q50890665

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Clinical efficacy and safety o ...... sover study (the MICRO study).

@en

Clinical efficacy and safety o ...... : A randomized crossover study

@nl

type

Item

label

Clinical efficacy and safety o ...... sover study (the MICRO study).

@en

Clinical efficacy and safety o ...... : A randomized crossover study

@nl

prefLabel

Clinical efficacy and safety o ...... sover study (the MICRO study).

@en

Clinical efficacy and safety o ...... : A randomized crossover study

@nl

P1476

Clinical efficacy and safety o ...... sover study (the MICRO study).

@en

P2093

Akihide Hirayama

http://www.w3.org/2001/XMLSchema#string

Atsushi Yamada

http://www.w3.org/2001/XMLSchema#string

Chie Matsushita

http://www.w3.org/2001/XMLSchema#string

Daisuke Goto

http://www.w3.org/2001/XMLSchema#string

Katsuya Aoki

http://www.w3.org/2001/XMLSchema#string

Kazumasa Torimoto

http://www.w3.org/2001/XMLSchema#string

Kiyohide Fujimoto

http://www.w3.org/2001/XMLSchema#string

Makito Miyake

http://www.w3.org/2001/XMLSchema#string

Nobumichi Tanaka

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Matsumoto

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline

Comparative Evaluation of the Safety and Efficacy of Long-Term Use of Imidafenacin and Solifenacin in Patients with Overactive Bladder: A Prospective, Open, Randomized, Parallel-Group Trial (the LIST Study)

The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial.

Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada

The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis.

Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison.

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.

Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder.

Is there seasonal variation in symptom severity, uroflowmetry and frequency-volume chart parameters in men with lower urinary tract symptoms?

Relationship between Toe Temperature and Lower Urinary Tract Symptoms.

P304

1097-1103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/NAU.23050

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27265880

http://www.w3.org/2001/XMLSchema#string